e-learning
resources
Munich 2006
Sunday 03.09.2006
New aspects in the pathogenesis of asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of chronic rhinosinusitis on clinical presentation in patients with asthma
Y. Oshita, T. Koga, T. Kamimura, H. Aizawa (Kurume, Japan)
Source:
Annual Congress 2006 - New aspects in the pathogenesis of asthma
Session:
New aspects in the pathogenesis of asthma
Session type:
Thematic Poster Session
Number:
1398
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Oshita, T. Koga, T. Kamimura, H. Aizawa (Kurume, Japan). Impact of chronic rhinosinusitis on clinical presentation in patients with asthma. Eur Respir J 2006; 28: Suppl. 50, 1398
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Impact of adult rhinosinusitis on asthma severity
Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Year: 2012
Effects of therapy for rhinosinusitis in signs and symptoms of asthma in children
Source: Eur Respir J 2007; 30: Suppl. 51, 383s
Year: 2007
Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Effects of exacerbation risk on symptoms and clinical characteristics in patients with bronchiectasis
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Impact of omalizumab in patients with severe asthma
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009
Evaluation of physical sings and symptoms in patients with acute exacerbation of COPD
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008
Acute severe asthma: evidence-based management of asthma exacerbations
Source: Annual Congress 2008 - PG4 - Paediatric respiratory medicine: wheezing children: asthma and beyond
Year: 2008
Characteristics of patients with persistent airflow obstruction from an asthma clinic
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
The use of omalizumab in the management of severe chronic paediatric asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008
Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma: SINUS-52 trial
Source: Virtual Congress 2020 – Phenotypes of asthma and COPD
Year: 2020
Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021
Prevalence of nasal symptoms and their relation to self-reported asthma and chronic bronchitis/emphysema
Source: Eur Respir J 2001; 17: 596-603
Year: 2001
Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial
Source: International Congress 2016 – Best abstracts in asthma and COPD
Year: 2016
Algorythm of differential diagnostics and further management of cough variant asthma in patients with chronic cough
Source: Eur Respir J 2003; 22: Suppl. 45, 372s
Year: 2003
Clinical and exacerbation characteristics may predict treatment response in acute exacerbations of COPD
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
Nocturnal respiratory symptoms in patients with chronic rhinosinusitis
Source: Annual Congress 2009 - Diagnostic aspects in obstructive sleep apnoea
Year: 2009
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 335s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept